Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Lexaria Bioscience Corp (LXX.CN)

Lexaria Bioscience Corp (LXX.CN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 47,162
  • Shares Outstanding, K 78,637
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta 4.30
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 10.57
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.05
  • Most Recent Earnings -0.01 on 05/31/19
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.530 +7.55%
on 10/02/19
0.950 -40.00%
on 09/18/19
-0.340 (-37.36%)
since 09/11/19
3-Month
0.530 +7.55%
on 10/02/19
1.270 -55.12%
on 08/12/19
-0.560 (-49.56%)
since 07/11/19
52-Week
0.530 +7.55%
on 10/02/19
2.460 -76.83%
on 10/16/18
-1.720 (-75.11%)
since 10/11/18

Most Recent Stories

More News
Lexaria Bioscience Provides Update on R&D Program Progress under License Agreement with Altria

KELOWNA, BC / ACCESSWIRE / October 8, 2019 / Lexaria Bioscience Corp. (OTCQX:LXRP) (CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, is pleased to provide this update...

LXRP : 0.4496 (-6.33%)
LXX.CN : 0.570 (-9.52%)
MO : 42.57 (-0.95%)
Peer Reviewed Clinical Journal Publishes Lexaria Bioscience's Human CBD Study Results

KELOWNA, BRITISH COLUMBIA / ACCESSWIRE / September 17, 2019 / Lexaria Bioscience Corp. (OTCQX:LXRP)(CSE:LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased...

LXRP : 0.4496 (-6.33%)
LXX.CN : 0.570 (-9.52%)
Technological Innovation Pushes Bounds of Edible Cannabis Market

A desire to move away from smoking may be fueling growth in the edible cannabis products. Sproutly Canada Inc. (OTCQB: SRUTF) (CSE: SPR) (FSE: 38G) (Profile) is developing new technology to manufacture...

VGW.CN : 3.960 (-1.25%)
VGW.VN : 2.790 (-2.79%)
LXX.CN : 0.570 (-9.52%)
LXRP : 0.4496 (-6.33%)
BEV.CN : 0.490 (-2.00%)
BVNNF : 0.3791 (+2.46%)
HEXO.TO : 3.35 (-10.90%)
HEXO : 2.53 (-11.23%)
VGWCF : 2.1310 (-1.80%)
SRUTF : 0.2700 (+3.25%)
SPR.CN : 0.355 (+1.43%)
Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Featured in NetworkNewsAudio Publication Discussing Innovative Drug-Delivery Discovery

via NetworkNewsAudio - Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) announces the availability of a NetworkNewsAudio publication titled, "Innovative Drug-Delivery Systems Benefit Patients and Businesses."...

LXX.CN : 0.570 (-9.52%)
LXRP : 0.4496 (-6.33%)
Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Featured in NetworkNewsWire Publication Reporting on Momentous Advances in Drug-Delivery Innovation

via NetworkWire -- Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company...

LXX.CN : 0.570 (-9.52%)
LXRP : 0.4496 (-6.33%)
Innovative Drug-Delivery Systems Benefit Patients and Businesses

Drugs play an essential role in treating anything from a mild headache to life-threatening disease -- and everything in between. While effectiveness of drugs is what most often captures the spotlight,...

SGEN : 82.60 (+1.29%)
EXEL : 16.52 (-0.06%)
AXSM : 18.14 (+2.98%)
PRVB : 6.05 (+2.37%)
LXX.CN : 0.570 (-9.52%)
LXRP : 0.4496 (-6.33%)
Lexaria Bioscience Announces DehydraTECH Patent for Pharmaceutical Applications of Cannabinoids to Treat Certain Disease Conditions

KELOWNA, BC / ACCESSWIRE / August 27, 2019 / Lexaria Bioscience Corp. (OTCQX:LXRP) (CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, is pleased to announce that it...

LXRP : 0.4496 (-6.33%)
LXX.CN : 0.570 (-9.52%)
Lexaria Announces Commercial Launch of ChrgD+ Odorless, Flavorless, Water-Soluble Powdered Hemp Oil

KELOWNA, BC / ACCESSWIRE / August 22, 2019 / Lexaria Bioscience Corp. (OTCQX:LXRP) (CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, is pleased to announce the online...

LXRP : 0.4496 (-6.33%)
LXX.CN : 0.570 (-9.52%)
Lexaria Announces Commercial Launch of ChrgD+ Odorless, Flavorless, Water-Soluble Powdered Hemp Oil

(via TheNewswire)

LXRP : 0.4496 (-6.33%)
LXX.CN : 0.570 (-9.52%)
More Companies Lining Up to Get Their Hands on Lexarias DehydraTECH Platform -- CFN Media

Seattle, Washington--(Newsfile Corp. - August 15, 2019) - CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry announces publication...

MO : 42.57 (-0.95%)
LXX.CN : 0.570 (-9.52%)
LXRP : 0.4496 (-6.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

2nd Resistance Point 0.683
1st Resistance Point 0.627
Last Price 0.570
1st Support Level 0.537
2nd Support Level 0.503

See More

52-Week High 2.460
Fibonacci 61.8% 1.723
Fibonacci 50% 1.495
Fibonacci 38.2% 1.267
Last Price 0.570
52-Week Low 0.530

See More

Business Summary

Lexaria Bioscience Corp is a food science company. The company's food sciences activities include the development of the proprietary nutrient infusion technologies for the production of superfoods, and the production of enhanced food products under two consumer product brands, ViPova and Lexaria Energy....

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar